← Leaderboards
Kathryn Elizabeth Lancaster
Ohio State University
$3,624,970
Attributed
$5,584,296
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,584,296 · 6
By mechanism
U01$2,528,513 · 1
K01$841,136 · 1
R01$762,479 · 1
R34$627,661 · 1
R61$575,433 · 1
R21$249,074 · 1
Top collaborators
- Angela Parcesepe3 shared
- Kathleen Louise Egan1 shared
- Christina S Meade1 shared
Most similar at Ohio State University
Same institution · by research overlap
- Nidia Quillinan$4,555,473
- Susan R Mallery$15,292,540
- Lei Cao$8,524,328
- Brian Lee Foster$5,187,892
- Sehun Oh$524,091
Others in their field
Other Emerging Leaders on “Uptake”
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Paula Gonzalez-Maya · Fundacion Inciensa$17,061,460
- Emmanuel Aja Oga · Research Triangle Institute$16,442,002
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,507,691
- Rainer Lohmann · University Of Rhode Island$14,400,221
Research focus
UptakeInterviewEnrollmentBehavioralPersonsEpidemicSkillsWomanTransmission ProcessSurveysInnovationUnited StatesHigh RiskInfectionRuralAids PreventionServicesPharmaceutical PreparationsFundingCountyPre-Exposure ProphylaxisCommunitiesNational Institute Of Drug AbuseComplex
Grant awards (13)
CASCADE: A North Carolina cohort to address the cascading effects of the HIV and substance use syndemic$2,528,513
U01 · FY2025 · DA
Integrated HIV and Overdose Prevention in Pharmacies: Assessing Availability and Implementation Strategies in Different Policy Environments (HIP-Pharm)$762,479
R01 · FY2025 · DA · contact PI
Hybrid Trial of Peer-Supported Affect Regulation and Contingency Management to Improve HIV Prevention Outcomes in the Southern United States$575,433
R61 · FY2025 · DA · contact PI
Enhancing HIV prevention and reducing alcohol use among people receiving STI care in Malawi: An HIV status neutral approach$203,440
R34 · FY2025 · AA
Enhancing HIV prevention and reducing alcohol use among people receiving STI care in Malawi: An HIV status neutral approach$203,981
R34 · FY2024 · AA
Enhancing HIV prevention and reducing alcohol use among people receiving STI care in Malawi: An HIV status neutral approach$220,240
R34 · FY2023 · AA
The role of injection partnerships and preferences for reducing HCV risk: Giving a voice to young women in rural Appalachia.$141,918
K01 · FY2023 · DA · contact PI
The role of injection partnerships and preferences for reducing HCV risk: Giving a voice to young women in rural Appalachia$22,530
K01 · FY2023 · DA · contact PI
The role of injection partnerships and preferences for reducing HCV risk: Giving a voice to young women in rural Appalachia$167,356
K01 · FY2022 · DA · contact PI
Measuring resilience to intersectional stigma for people who inject drugs in need of HIV prevention$249,074
R21 · FY2021 · DA · contact PI
The role of injection partnerships and preferences for reducing HCV risk: Giving a voice to young women in rural Appalachia$168,808
K01 · FY2021 · DA · contact PI
The role of injection partnerships and preferences for reducing HCV risk: Giving a voice to young women in rural Appalachia$170,262
K01 · FY2020 · DA · contact PI
The role of injection partnerships and preferences for reducing HCV risk: Giving a voice to young women in rural Appalachia$170,262
K01 · FY2019 · DA · contact PI